Therapies like PRP and ACS have gained credibility when properly applied and studied, particularly in musculoskeletal conditions.

AI in cancer research has moved decisively past theory. The focus is now on how to gain researchers' and clinicians' trust.

Investigational ADC QLS5132 showed promising clinical benefit and manageable safety in Phase I trial patients with platinum-resistant ovarian cancer.

The gene editing treatment targets the relatively common 1717-1G>A splicing mutation, which does not respond to many current CF therapies.

The results of a study by researchers at the International Centre for Genetic Engineering and Biotechnology (ICGEB) suggest that the heart’s constant beating may actively suppress tumor growth in ...

At AACR, first‑in‑human KIR‑CAR T data show early activity in solid tumors and introduce a novel design aimed at limiting T ...

Discovery that astrocyte networks shrink and reroute after a loss of sensory signals suggests they may be shaped by experience.

Researchers explored the cellular cross-talk between endothelial cells and macrophages contributing to peripheral vascular ...

Viral safety will be a major challenge for the CGT industry for the foreseeable future, according to new analysis.

At the 2026 BiOS conference in San Francisco, researchers presented a biosensing platform aimed at improving how living cells and tissues are monitored during drug bioprocessing. Known as TissueSense, ...

Integrated, process-savvy technologies are vital to overcoming the virus-like particles purification bottleneck.

These “on‑demand” probes, known as VIS‑Fbs, become brightly fluorescent only when they bind their intended protein targets.